Open Access
Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation
Тип публикации: Journal Article
Дата публикации: 2015-02-26
SCImago Q1
Tоп 10% SCImago
WOS Q1
БС1
SJR: 1.339
CiteScore: 20.2
Impact factor: 8
ISSN: 10717544, 15210464
PubMed ID:
25715807
General Medicine
Pharmaceutical Science
Краткое описание
Abstract Context: Development of carvedilol-loaded transfersomes for intranasal administration to overcome poor nasal permeability and hepatic first pass effect so as to enhance its bioavailability. Objective: The purpose of this study was to develop carvedilol-loaded transfersomes containing different edge activators (EAs) then evaluating the in vivo behavior of the optimized formula in rabbits. Methods: The vesicles were prepared by incorporating different EAs including Span 20, Span 60, Tween 20, Tween 80, and sodium deoxycholate (SDC) in the lipid bilayer and each EA was used in three different ratios with respect to phosphatidylcholine (PC) including 95:5%, 85:15%, and 75:25% w/w (PC:EA). Evaluation of transfersomes was carried out in terms of shape, size, entrapment efficiency (EE), in vitro release, ex vivo permeation, confocal laser scanning microscopy (CLSM), and stability studies. The pharmacokinetic study of the optimized formula was conducted in rabbits. Results: The mean diameter of the vesicles was in the range of 295–443 nm. Transfersomes prepared with 95:5% (w/w) (PC:EA) ratio showed highest EE% where Span 60 gave the highest values. Whereas those prepared using 85:15% w/w ratio showed highest percentages of drug release where SDC was superior to other EAs. The developed transfersomes exhibited significantly higher amounts of carvedilol permeated through nasal mucosa. CLSM of formula T14 containing SDC with 85:15% (w/w) (PC:EA) ratio revealed high permeation across the nasal mucosa. Conclusion: The nanotransfersomal vesicles were significantly more efficient in nasal delivery of carvedilol with absolute bioavailability of 63.4%.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.
Топ-30
Журналы
|
2
4
6
8
10
12
14
16
|
|
|
Journal of Drug Delivery Science and Technology
16 публикаций, 13.11%
|
|
|
Pharmaceutics
11 публикаций, 9.02%
|
|
|
AAPS PharmSciTech
7 публикаций, 5.74%
|
|
|
Drug Delivery
7 публикаций, 5.74%
|
|
|
Drug Delivery and Translational Research
6 публикаций, 4.92%
|
|
|
International Journal of Nanomedicine
6 публикаций, 4.92%
|
|
|
Journal of Pharmaceutical Sciences
5 публикаций, 4.1%
|
|
|
International Journal of Pharmaceutics
5 публикаций, 4.1%
|
|
|
Pharmaceuticals
4 публикации, 3.28%
|
|
|
Molecules
3 публикации, 2.46%
|
|
|
International Journal of Biological Macromolecules
3 публикации, 2.46%
|
|
|
Journal of Liposome Research
3 публикации, 2.46%
|
|
|
Journal of Pharmaceutical Innovation
3 публикации, 2.46%
|
|
|
Gels
2 публикации, 1.64%
|
|
|
European Journal of Pharmaceutical Sciences
2 публикации, 1.64%
|
|
|
Drug Development and Industrial Pharmacy
2 публикации, 1.64%
|
|
|
BioNanoScience
2 публикации, 1.64%
|
|
|
Russian Chemical Reviews
1 публикация, 0.82%
|
|
|
Current Drug Delivery
1 публикация, 0.82%
|
|
|
Cardiology in Review
1 публикация, 0.82%
|
|
|
Materials
1 публикация, 0.82%
|
|
|
Nanomaterials
1 публикация, 0.82%
|
|
|
DARU, Journal of Pharmaceutical Sciences
1 публикация, 0.82%
|
|
|
Phytomedicine
1 публикация, 0.82%
|
|
|
Life Sciences
1 публикация, 0.82%
|
|
|
Journal of Controlled Release
1 публикация, 0.82%
|
|
|
Neuropharmacology
1 публикация, 0.82%
|
|
|
Journal of King Saud University - Science
1 публикация, 0.82%
|
|
|
Biomedicine and Pharmacotherapy
1 публикация, 0.82%
|
|
|
2
4
6
8
10
12
14
16
|
Издатели
|
5
10
15
20
25
30
35
40
45
|
|
|
Elsevier
44 публикации, 36.07%
|
|
|
MDPI
23 публикации, 18.85%
|
|
|
Taylor & Francis
21 публикация, 17.21%
|
|
|
Springer Nature
20 публикаций, 16.39%
|
|
|
Wiley
3 публикации, 2.46%
|
|
|
Bentham Science Publishers Ltd.
2 публикации, 1.64%
|
|
|
American Chemical Society (ACS)
2 публикации, 1.64%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 0.82%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 0.82%
|
|
|
King Saud University
1 публикация, 0.82%
|
|
|
Oxford University Press
1 публикация, 0.82%
|
|
|
AIP Publishing
1 публикация, 0.82%
|
|
|
Frontiers Media S.A.
1 публикация, 0.82%
|
|
|
Royal Society of Chemistry (RSC)
1 публикация, 0.82%
|
|
|
5
10
15
20
25
30
35
40
45
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Войти с ORCID
Метрики
122
Всего цитирований:
122
Цитирований c 2025:
20
(16.4%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Aboud H. M. et al. Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation // Drug Delivery. 2015. Vol. 23. No. 7. pp. 2471-2481.
ГОСТ со всеми авторами (до 50)
Скопировать
Aboud H. M., Ben Ali A., Elmenshawe S., Elbary A. A. Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation // Drug Delivery. 2015. Vol. 23. No. 7. pp. 2471-2481.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.3109/10717544.2015.1013587
UR - https://doi.org/10.3109/10717544.2015.1013587
TI - Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation
T2 - Drug Delivery
AU - Aboud, Heba M
AU - Ben Ali, Adel
AU - Elmenshawe, Shahira
AU - Elbary, Ahmed Abd
PY - 2015
DA - 2015/02/26
PB - Taylor & Francis
SP - 2471-2481
IS - 7
VL - 23
PMID - 25715807
SN - 1071-7544
SN - 1521-0464
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2015_Aboud,
author = {Heba M Aboud and Adel Ben Ali and Shahira Elmenshawe and Ahmed Abd Elbary},
title = {Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation},
journal = {Drug Delivery},
year = {2015},
volume = {23},
publisher = {Taylor & Francis},
month = {feb},
url = {https://doi.org/10.3109/10717544.2015.1013587},
number = {7},
pages = {2471--2481},
doi = {10.3109/10717544.2015.1013587}
}
Цитировать
MLA
Скопировать
Aboud, Heba M., et al. “Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation.” Drug Delivery, vol. 23, no. 7, Feb. 2015, pp. 2471-2481. https://doi.org/10.3109/10717544.2015.1013587.
Ошибка в публикации?